Sumpatan, Noralyn T.

HRN: 23-18-32  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2026
CO-AMOXICLAV 625MG (TAB)
05/21/2026
05/27/2026
PO
625mg
BID
UTI Following Delivery
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines